Gene construct encoding mutant thioesterase, mutant thioesterase encoded thereby, transformed host cell containing the gene construct, and method of using them to produce medium-chain fatty acids

Patent metadata

Field	Value
Publication number	US-11053480-B2
Application number	US-202015930147-A
Country	US
Kind code	B2
Filing date	May 12, 2020
Priority date	Jun 22, 2016
Publication date	Jul 6, 2021
Grant date	Jul 6, 2021

Abstract

Unnatural, mutated thioesterases having an amino acid sequence that is at least 80% identical to SEQ. ID. NO: 1 and having substitutions at one or more of amino acid positions I107, R108, L109, S122, M141, E142, Y145, and L146, gene constructs encoding and configured to express the mutated thioesterases in a transformed host cell and host cells transformed to contain the gene constructs.

First claim

What is claimed is:

1. An unnatural, mutated protein comprising an amino acid sequence that is at least 85% identical to SEQ ID NO:1 and comprises a substitution at a position aligning to I107 of SEQ ID NO:1, a position aligning to R108 of SEQ ID NO:1, a position aligning to S122 of SEQ ID NO:1, a position aligning to M141 of SEQ ID NO:1, a position aligning to Y145 of SEQ ID NO:1, a position aligning to L146 of SEQ ID NO:1, or a combination thereof, wherein:
the protein comprises a phenylalanine at the position aligning to Y145 of SEQ ID NO:1; and
the protein has at least one of enhanced thioesterase activity and enhanced thioesterase specificity in catalyzing the hydrolysis of a medium-chain acyl-acyl carrier protein substrate or a medium-chain acyl-CoA substrate to yield a free fatty acid or a free fatty acid derivative compared to an unaltered protein of SEQ ID NO:1.

2. The protein of claim 1 , wherein the protein further comprises at least one of:
a phenylalanine at the position aligning to R108 of SEQ ID NO:1;
a phenylalanine at a position aligning to L109 of SEQ ID NO:1;
a methionine at the position aligning to S122 of SEQ ID NO:1;
a leucine at the position aligning to M141 of SEQ ID NO:1;
a proline at a position aligning to E142 of SEQ ID NO:1; and
a proline at the position aligning to L146 of SEQ ID NO:1.

3. The protein of claim 1 , wherein the protein further comprises at least two of:
a phenylalanine at the position aligning to R108 of SEQ ID NO:1;
a phenylalanine at a position aligning to L109 of SEQ ID NO:1;
a methionine at the position aligning to S122 of SEQ ID NO:1;
a leucine at the position aligning to M141 of SEQ ID NO:1;
a proline at the position aligning to E142 of SEQ ID NO:1; and
a proline at the position aligning to L146 of SEQ ID NO:1.

4. The protein of claim 1 , wherein the protein further comprises at least two of:
a phenylalanine at the position aligning to R108 of SEQ ID NO:1;
a phenylalanine at a position aligning to L109 of SEQ ID NO:1;
a methionine at the position aligning to S122 of SEQ ID NO:1; and
a proline at the position aligning to L146 of SEQ ID NO:1.

5. The protein of claim 1 , wherein the protein further comprises a phenylalanine at the position aligning to R108 of SEQ ID NO:1.

6. The protein of claim 5 , wherein the protein further comprises at least one of:
a phenylalanine at a position aligning to L109 of SEQ ID NO:1; and
a proline at the position aligning to L146 of SEQ ID NO:1.

7. The protein of claim 5 , wherein the protein comprises a phenylalanine at a position aligning to L109 of SEQ ID NO:1.

8. The protein of claim 5 , wherein the protein comprises a proline at the position aligning to L146 of SEQ ID NO:1.

9. The protein of claim 5 , wherein the protein comprises:
a phenylalanine at a position aligning to L109 of SEQ ID NO:1; and
a proline at the position aligning to L146 of SEQ ID NO:1.

10. The protein of claim 9 , wherein the protein further comprises a methionine at the position aligning to S122 of SEQ ID NO:1.

11. The protein of claim 1 , wherein the protein further comprises at least two of:
a methionine at the position aligning to S122 of SEQ ID NO:1;
a leucine at the position aligning to M141 of SEQ ID NO:1; and
a proline at a position aligning to E142 of SEQ ID NO:1.

12. The protein of claim 1 , wherein the protein further comprises at least one of:
a leucine at the position aligning to M141 of SEQ ID NO:1; and
a proline at a position aligning to E142 of SEQ ID NO:1.

13. The protein of claim 1 , wherein the protein further comprises:
a leucine at the position aligning to M141 of SEQ ID NO:1; and
a proline at a position aligning to E142 of SEQ ID NO:1.

14. The protein of claim 13 , wherein the protein further comprises a methionine at the position aligning to S122 of SEQ ID NO:1.

15. The protein of claim 1 , wherein the protein comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 1.

16. The protein of claim 1 , wherein the protein comprises an amino acid sequence that is at least 95% identical to SEQ ID NO: 1.

17. A gene construct encoding the protein of claim 1 .

18. The gene construct of claim 17 , comprising a nucleotide regulatory sequence operationally connected to nucleotides encoding the protein, wherein the regulatory sequence is dimensioned and configured to drive expression of the protein in a host cell transformed to contain the gene construct.

19. A host cell transformed to contain and express a gene construct encoding the protein of claim 1 .

20. The host cell of claim 19 , which is selected from the group consisting of a transformed microbe, a transformed eukaryote, a transformed prokaryote, and a transformed plant cell.

Assignees

• Wisconsin Alumni Res Found
• Penn State Res Found

Inventors

• Pfleger Brian F
• Hernandez-Lozada Nestor Jose
• Maranas Costas
• Grisewood Matthew

Classifications

• C12Y301/02002

  Palmitoyl-CoA hydrolase (3.1.2.2) · CPC title

• C12N9/16 Primary

  acting on ester bonds (3.1) · CPC title